The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Open accessAbstract
OBJECTIVE: To evaluate the efficiency of mitoxantrone in multiple sclerosis. METHODS: Forty two patients with confirmed multiple sclerosis, selected as having a very active disease on clinical and MRI criteria were randomised to receive either mitoxantrone (20 mg intravenously (IV) monthly) and methylprednisolone (1 g iv monthly) or methylprednisolone alone over six months. In the steroid alone group five patients dropped out due to severe exacerbation. RESULTS: Blinded analysis of MRI data showed significantly more patients with no new enhancing lesions in the mitoxantrone group compared with the steroid alone group, (90% v 31%, P < 0.001). In the mitoxantrone group there was a month by month decrease almost to zero in the number of new enhancing lesions, and in the total number of enhancing lesions, whereas both remained high in the steroid alone group. The differences were significant for both indices at all months from 1-6. Unblinded clinical assessments showed a significant improvement in change in EDSS at months 2-6 in the mitoxantrone group, with a final mean improvement of more than one point (-1.1 v + 0.3; P < 0.001). There was a significant reduction in the number of relapses (7 v 31; P < 0.01), and an increase in the number of patients free of exacerbation (14 v 7; P < 0.05). CONCLUSION: In this selected group of patients with multiple sclerosis with very active disease, mitoxantrone combined with methylprednisolone was effective in improving both clinical and MRI indices of disease activity over a period of six months whereas methylprednisolone alone was not. Further double blinded long term studies are needed to properly evaluate the effect of mitoxantrone on progression in disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
The IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.655 · Cited by 2,085
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444
Self-citationMiller, D. H., Barkhof, F., Berry, I., Kappos, L., Scotti, G., & Thompson, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.8.683 · Cited by 370
Self-citationMcFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 346
EDMUS, a European database for multiple sclerosis.
Confavreux, C., Compston, D. A., Hommes, O. R., McDonald, W. I., & Thompson, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.671 · Cited by 313
Self-citationGoodkin, D. E., Rudick, R. A., Medendorp, S. V., Daughtry, M. M., Schwetz, K. M., Fischer, J., & van Dyke, C. (1995) · Annals of Neurology · doi:10.1002/ana.410370108 · Cited by 304
Miller, D. H., Barkhof, F., & Nauta, J. J. P. (1993) · Brain · doi:10.1093/brain/116.5.1077 · Cited by 256
Self-citationWeiner, H. L., Mackin, G. A., Orav, E. J., Hafler, D. A., Dawson, D. M., LaPierre, Y., Herndon, R., Lehrich, J. R., Hauser, S. L., Turel, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.5.910 · Cited by 248
Stone, L. A., Frank, J. A., Albert, P. S., Bash, C., Smith, M. E., Maloni, H., & McFarland, H. F. (1995) · Annals of Neurology · doi:10.1002/ana.410370511 · Cited by 247
The Multiple Sclerosis Study Group, & Wolinsky (1990) · Annals of Neurology · doi:10.1002/ana.410270603 · Cited by 217
Miller, D. H., Thompson, A. J., Morrissey, S. P., MacManus, D. G., Moore, S. G., Kendall, B. E., Moseley, I. F., & McDonald, W. I. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.6.450 · Cited by 188
Self-citationMoreau, T., Scolding, N., Compston, A., Thorpe, J., Miller, D., Moseley, I., Hale, G., Waldmann, H., Clayton, D., Wing, M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91339-0 · Cited by 187
Self-citationCognitive change following MPTP exposure
Stern, Y., Tetrud, J. W., Martin, W. R. W., Kutner, S. J., & Langston, J. W. (1990) · Neurology · doi:10.1212/wnl.40.2.261 · Cited by 146
Stone, L. A., Smith, M. E., Albert, P. S., Bash, C. N., Maloni, H. W., Frank, J. A., & McFarland, H. F. (1995) · Neurology · doi:10.1212/wnl.45.6.1122 · Cited by 130
Fidler, J. M., DeJoy, S. Q., & Gibbons, J. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.2.727 · Cited by 124
Kappos, L., Pätzold, U., Dommasch, D., Poser, S., Haas, J., Krauseneck, P., Malin, J. P., Fierz, W., Graffenried, B. U., & Gugerli, U. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230110 · Cited by 112
Suppression of experimental allergic encephalomyelitis by mitoxantrone
Ridge, S. C., Sloboda, A. E., McReynolds, R. A., Levine, S., Oronsky, A. L., & Kerwar, S. S. (1985) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(85)90075-3 · Cited by 94
An open‐trial evaluation of mitoxantrone in the treatment of progressive MS
Noseworthy, J. H., Hopkins, M. B., Vandervoort, M. K., et al. (1993) · Neurology · doi:10.1212/wnl.43.7.1401 · Cited by 85
Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone
LUBLIN, F. D., Lavasa, M., Viti, C., & Knobler, R. L. (1987) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(87)90118-8 · Cited by 76
Levine, S., & Saltzman, A. (1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90063-9 · Cited by 55
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Hartung, H.-P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrissey, S. P., Krapf, H., & Zwingers, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12023-x · Cited by 946
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Barkhof, F., Calabresi, P. A., Miller, D. H., & Reingold, S. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.41 · Cited by 378
Self-citation
Metadata
- Authors
- Edan, G., Miller, D., Clanet, M., Confavreux, C., Lyon-Caen, O., Lubetzki, C., Brochet, B., Berry, I., Rolland, Y., Froment, J. C., Cabanis, E., Iba-Zizen, M. T., Gandon, J. M., Lai, H. M., Moseley, I., & Sabouraud, O.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1997-02-01
- Volume
- 62
- Issue
- 2
- Pages
- 112-118
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2012054969
- Cited by
- 425
- References
- 22
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.